Pnc Financial Services Group, Inc. Travere Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 20 shares of TVTX stock, worth $458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 20
-0.0%
Holding current value
$458
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TVTX
# of Institutions
211Shares Held
91.8MCall Options Held
882KPut Options Held
811K-
Black Rock Inc. New York, NY7.64MShares$175 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$169 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$154 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$114 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$97.6 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.47B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...